Amedisys Announces Second Quarter 2022 Earnings Release and Conference Call Date

Rhea-AI Summary

Amedisys (NASDAQ: AMED) will disclose its Q2 results on July 27, 2022, post-market, with a conference call scheduled for July 28, 2022, at 11:00 a.m. ET. Investors can access the call by dialing toll-free numbers or via a live webcast on the company's investor relations site. Amedisys is dedicated to providing high-quality home health, hospice, personal care, and high-acuity care services across the U.S., partnering with over 3,000 hospitals and 90,000 physicians to deliver care to more than 445,000 patients annually.

Positive

• Amedisys has a vast network, serving over 445,000 patients each year.
• The company partners with more than 3,000 hospitals and 90,000 physicians, enhancing its market presence.

Negative

• None.

BATON ROUGE, La., July 06, 2022 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED), a leading provider of quality home health, hospice, personal care and high-acuity care, will report results for the second quarter ended June 30, 2022, after the market closes on July 27, 2022. The Company will host an investor conference call to discuss these results at 11:00 a.m. ET on July 28, 2022.

To participate on the conference call, please call a few minutes before 11:00 a.m. ET to either (877) 524-8416 (toll-free) or (412) 902-1028 (toll). A replay of the call will be available through August 28, 2022, by dialing (877) 660-6853 (toll-free) or (201) 612-7415 (toll) and entering access ID 13731294.

A live webcast of the call will be accessible through the Company website on the Investor Relations section at https://investors.amedisys.com.

About Amedisys:

Amedisys, Inc. is a leading healthcare at home Company delivering personalized home health, hospice, personal care and high-acuity care services. Amedisys is focused on delivering the care that is best for our patients, whether that is home-based personal care; inpatient hospital, palliative, and skilled nursing facility (“SNF”) care in their homes; recovery and rehabilitation after an operation or injury; care focused on empowering them to manage a chronic disease; or hospice care at the end of life. More than 3,000 hospitals and 90,000 physicians nationwide have chosen Amedisys as a partner in post-acute care. Founded in 1982, headquartered in Baton Rouge, LA with an executive office in Nashville, TN, Amedisys is a publicly held company. With approximately 21,000 employees, in 549 care centers in 38 states and the District of Columbia, Amedisys is dedicated to delivering the highest quality of care to the doorsteps of more than 445,000 patients in need every year, performing more than 11.5 million visits annually. For more information about the Company, please visit: www.amedisys.com.

Contact:
Nick Muscato	Kendra Kimmons
Amedisys, Inc.	Amedisys, Inc.
Investor Relations	Media Relations
615.928.5452	225.299.3720
nick.muscato@amedisys.com	Kendra.kimmons@amedisys.com

FAQ

When will Amedisys announce its Q2 earnings for 2022?

Amedisys will announce its Q2 earnings on July 27, 2022, after the market closes.

What time is the Amedisys Q2 earnings conference call?

The conference call for Amedisys's Q2 earnings will be held at 11:00 a.m. ET on July 28, 2022.

How can I listen to Amedisys's Q2 earnings call?

You can listen to the Amedisys Q2 earnings call by dialing the toll-free numbers provided or through a live webcast on the company's investor relations website.